Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Jun 17;41(4):857–873. doi: 10.1177/0271678X20931137

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2020

PMC Copyright notice

Figure 1. — Gal3 reduces brain damage induced by focal cerebral ischemia. (a) Schematic representation of experimental design in rat MCAO model. (b) Representative photographs of coronal brain sections stained with 2,3,5-triphenyltetrazolium chloride (TTC) showing reduced infarct volume in Gal3-treated animals as compared to control saline-treated animals. (c) Quantitation of cerebral infarct volume in brains was analyzed using Image J program. The infarct volume is significantly lower in the Gal3-treated group compared with the control saline group. The infarct volume is expressed as the percentage of the contra lateral hemispheric area (N = 10). Data are expressed as mean ± SD, **P < 0.01 control/saline MCAO group vs. Gal3/MCAO group.